Amgen Inc (HKSE:04332)
HK$ 1761 0 (0%) Market Cap: 1.17 Til Enterprise Value: 1.57 Til PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 92/100

Amgen Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 12:50PM GMT
Release Date Price: HK$1850
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Great. Good morning, everybody. Thanks for joining us. I'm Terence Flynn, the U.S. Pharma & Biotech analyst here at Morgan Stanley. We're very pleased to be hosting Amgen. Today, from the company, we have Bob Bradway, who is the company's Chairman and CEO.

Before we get started for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

Bob, before you launch into my questions, I'll turn it over to you for some opening remarks, but thanks so much for your time today.

Robert A. Bradway
Amgen Inc. - Chairman, CEO & President

Thank you, Terence. Thanks for having us, and thank you all for joining us. Perhaps, before we get started, I might just say a word or 2 about Horizon. I know Terence probably won't be in a position

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot